Nurse Practitioner Swope works closely with each patient to develop personalized treatment plans that address their unique needs, preferences, and goals
Retatrutide, Eli Lilly's next obesity drug, fueled dramatic weight loss in clinical trial Retatrutide, Eli Lillys next generation of weight loss injections, showed dramatic results in clinical trials, with patients losing an average of up to 71.2 pounds, or 28.7% of their body weight
Some achieve their goals at 5mg or 7.5mg and maintain there
The term "oral peptide" in consumer usage encompasses any GLP-1 medication designed for non-injectable administration
Book Your Maintenance Consultation Program Benefits Continuous access to GLP-1 medication support Adjustments based on your progress and body response Comprehensive care from licensed professionals Flexible scheduling to fit your lifestyle Stay in control of your results and keep the progress going
Grandt AD, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, et al